The prognosis for acute myeloid leukemia (AML) after all treatments fail varies significantly among individuals. Generally, the median survival time after treatment failure is limited, often ranging from a few weeks to several months, depending on factors such as the patient's overall health, age, and specific disease characteristics. Some patients may enter a phase of relapse or progression that can further affect survival. Palliative care can help manage symptoms and improve quality of life during this time.
Lalitha Nagarajan has written: 'Acute myelogenous leukemia' -- subject(s): Leukemia, Myeloid, Acute, Genetics, Acute myeloid leukemia, Therapy
Yes
The most common leukemia in a man above 40 is Acute Myeloid Leukemia.
I believe Leukemia has to do with blood, and therefore cells. So, I do not believe so.
Risk factors are any factor that would affect the chance that you would get a disease. Some Risk factors of Acute Myeloid Leukemia are but not limited to: smoking, certain chemical exposures, radiation exposure, certain blood disorders, congenital syndromes, having an identical twin with Acute Myeloid Leukemia, gender, and uncertain, unproven, or controversial risk factors.
Janet Frame died at age 79 of acute myeloid leukemia.
The main types of leukemia are classified into four primary categories: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). Acute leukemias, such as ALL and AML, progress rapidly, while chronic leukemias, including CLL and CML, typically develop more slowly. Each type has distinct characteristics, treatment approaches, and prognoses.
Leukemia is a cancer that affects the blood and bone marrow. It is characterized by the abnormal production of white blood cells, which are essential for the immune system. In leukemia, the bone marrow produces large numbers of abnormal white blood cells that do not function properly. These leukemia cells can crowd out normal blood cells, leading to problems with blood clotting, anemia, and a weakened immune system. There are different types of leukemia, and they are classified based on the type of white blood cell affected (lymphoid or myeloid) and whether the disease is acute or chronic. Acute leukemia progresses rapidly and requires immediate treatment, while chronic leukemia progresses more slowly and may not cause symptoms for many years. Common types of leukemia include acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). The specific type of leukemia and its classification influence the treatment approach and prognosis for individuals affected by the disease.
Trevor Szold died on April 26, 2010, in San Diego, California, USA of acute myeloid leukemia.
Michaelina Bellamy died on April 7, 2012, in Las Vegas, Nevada, USA of acute myeloid leukemia.
The time it takes for leukemia to become fatal varies significantly depending on several factors, including the type of leukemia, the stage at diagnosis, the patient's overall health, and response to treatment. Acute forms, such as acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), can progress rapidly, sometimes leading to death within weeks to months if untreated. Chronic forms, like chronic lymphocytic leukemia (CLL) or chronic myeloid leukemia (CML), may develop over years, allowing for more effective management and treatment options. Early diagnosis and treatment can significantly improve survival rates.
Blair Milan died on April 17, 2011, in Sydney, New South Wales, Australia of acute myeloid leukemia.